Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by Gman620on Apr 08, 2022 11:25am
287 Views
Post# 34587950

Signing up new trial patients

Signing up new trial patients
If you put yourself in the shoes of someone who was told that they have bladder cancer, and may possibly lose their bladder or worse, it becomes easier to see why it is difficult to sign people up for the clinical trial. If your doctor says that the standard protocol is BCG, even with low success rates, then a person is more likely to follow that path than possibly  risk their life on this unproven treatment.

I would ask "how many people have taken this treatment and what is the outcome?". It's a catch 22. There aren't enough results to make most people comfortable with trying this. 450 days is a long time if cancer has a chance to grow.

Hopefully when the small current sample has more results, it will help to create some momentum. The doctors need to believe in it.
<< Previous
Bullboard Posts
Next >>